Skip to main content
. 2020 Nov 1;59(21):2653–2660. doi: 10.2169/internalmedicine.5102-20

Table 2.

Changes in Scores of PROs in Patients with HCV Infection from the Beginning of Treatment to 3 Years Later.

Start of DAA 3 years later p value
CSS 6.2 (4.158) 5.13 (4.032) 0.0084
K-6 2.36 (2.993) 2.03 (3.483) 0.3311
PD in K-6 2 3 1
ESS 3.51 (83.189) 3.56 (3.295) 0.8509
PSQI 6.89 (3.256) 6.3 (2.721) 0.0391
RLS 13 9 0.4986
SF-36:PFN 43.6 (12.614) 42.47 (14.824) 0.3599
SF-36:RPN 43.78 (12.24) 45.03 (12.28) 0.378
SF-36:BPN 48.87 (10.9) 48.99 (10.61) 0.8163
SF-36:GHN 43.54 (89.09) 47.35 (8.08) <0.0001
SF-36:VTN 48.6 (10.97) 49.25 (9.6) 0.5487
SF-36:SFN 47.15 (11.234) 49.19 (9.49) 0.0996
SF-36:REN 45.22 (12.59) 47.12 (12.1) 0.1311
SF-36:MHN 50.75 (9.43) 49.21 (9.14) 0.1571
SF-36:PCS 43.11 (12.53) 43.49 (12.73) 0.6908
SF-36:MCS 50.9 (8.831) 51.87 (8.387) 0.3278
SF-36:RCS 47.36 (12.06) 48.19 (11.55) 0.6383

Data are presented as mean (SD).

CSS: Cirrhosis-related symptom score, ESS: Epworth sleepiness score, K-6: Kessler 6 score, PRO: patient-reported outcome, PSQI: Pittsburgh sleep quality index, BPN: bodily pain, SF-36, GHN: general health, MCS: mental component summary, MHN: mental health, NS: not significant, PCS: physical component summary, PFN: physical functioning, RCS: role/social component summary, REN: role emotional, RPN: role physical, SFN: social functioning, VTN: vitality, RLS: restless legs syndrome, PD: psychological distress